article thumbnail

Data Breach Affects 120,000 Priority Health Plan Members

HIPAA Journal

That investigation confirmed that the attackers had gained access to parts of its network that contained the protected health information of approximately 120,000 members of Priority Health’s health plans. MultiCare Health System says 18,615 Patients Affected by Avamere Health Services Cyberattack.

article thumbnail

CMS Updates IPPS Rates, Wage Index and DSH Uncompensated Care in 2024 Final Rule

Hall Render

This new Final Rule counts days of patients who receive from the demonstration (1) health insurance that covers inpatient hospital services or (2) premium assistance that covers 100 percent of the premium cost to the patient, which the patient uses to buy health insurance that covers inpatient hospital services.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

October-December 2021 State Regulatory Developments

New Jersey Healthcare Blog

Below are the most recent health care related regulatory developments as published in the New Jersey Register from October-December 2021: On October 4, 2021, at 53 N.J.R. 103, which declared a Public Health Emergency for the state in response to COVID-19. 1657(a), the Commissioner released a notice regarding Executive Order No.

article thumbnail

Telehealth Awareness, Access and Adoption: Updates from J.D. Power, the ATA and FAIR Health

Health Populi

Power,” your mind probably imagines reviews of automotive performance, retail shopping experiences, or perhaps even health insurance plan customer service. Expanding its report-card role in the health ecosystem. That is, mental health issues. health care system. When you think “J.D.

article thumbnail

FDA and Off-Label Communication – Getting Closer to Truth

Drug & Device Law

IMS Health Inc. , 2012); Amarin Pharma, Inc. First, such communications may now be directed to any health care provider – not just health insurers seeking to determine whether an off-label use should be covered, as was previously the case. E.g. , Sorrell v. 552 (2011); Thompson v. 357 (2002); United States v.

FDA 64